"Stud Or Dud" Dating App Launches A Platform For Background Checking Prospective Matches

Lilly Slides After New Obesity Pill Prescription Data Disappoints Wall Street Shares of Eli Lilly & Co. fell in New York premarket trading after new industry prescription data for the drugmaker's blockbuster obesity shot Zepbound and recently approved oral weight-loss pill Foundayo disappointed Wall Street analysts. Foundayo generated 3,707 prescriptions in its second week, according to new prescription-tracking data from IQVIA cited by RBC Capital Markets analysts. That compares with 18,410 prescriptions for Novo's oral version of Wegovy during its second week after launch, suggesting Lilly's weight-loss drugs are falling behind...

US Intelligence Community Assessed That Massive US Attack 'Unlikely' To Oust Iranian Regime: WaPo Even a massive military assault on Iran is unlikely to topple the Islamic Republic of Iran and its state system, according to a classified assessment produced by the US intelligence community shortly before the US and Israel launched their current 'shock and awe-style' military campaign on Tehran. The Washington Post first reported it, perhaps based on some kind of leak or briefing by an anonymous intelligence official, and calls it— a sobering assessment as the Trump administration...

Appeals Court Revives Tylenol Autism Lawsuits Against Kenvue A federal appeals court has breathed new life into litigation accusing Kenvue of failing to disclose alleged risks tied to taking Tylenol during pregnancy, reversing an earlier ruling that had effectively stopped hundreds of cases, according to a new report from Bloomberg. On Monday, the 2nd U.S. Circuit Court of Appeals concluded that the trial judge went too far in throwing out testimony from three expert witnesses. The panel said the experts relied on recognized scientific approaches and that disagreements over how to...